Cutaneous Lymphoma or Not? Looks like CTCL but polyclonal TCR

This discussion focuses on the complexities of diagnosing cutaneous T-cell lymphoma (CTCL), especially when traditional methods suggest lymphoma but T-cell receptor (TCR) analysis yields polyclonal results. The speaker describes the challenge of determining treatment plans in cases where clinical evidence indicates lymphoma but clonality testing does not support it using TCR. They emphasize that mutations associated with cancer can be present even if TCR shows polyclonal results, suggesting alternative methods such as next-generation sequencing (NGS) that analyze somatic mutations rather than relying solely on TCR for confirmation. Two patient cases illustrate these points, where patients initially misdiagnosed with lichenoid dermatitis progressed to more severe conditions, culminating in definitive cancer mutations being identified via NGS, thus aiding in accurate diagnosis and targeted treatment decisions. The speaker stresses the importance of these advanced diagnostic tools in guiding treatment, particularly in refractory cases, and highlights the evolving landscape of genomic testing in lymphomas for better patient outcomes. They conclude by encouraging the use of insurance billable NGS panels to enhance diagnostic accuracy and therapeutic strategies in complex lymphoma cases.